SCHEMBL25339641

SCHEMBL25339641

FC(F)(F)c1ccc(Nc2nccnc2-c2ccc3c(Cl)ncnc3c2)cc1

nearest known ligand 0.62

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
▸ TRPV1 Q8NER1 17/20 0.62
▸ EGFR P00533 1/20 0.48
▸ CNR1 P21554 1/20 0.46
▸ EPHX2 P34913 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25339743 0.87 TRPV1 (0.62) TRPV1EGFREPHX2
SCHEMBL25951982 0.86 TRPV1 (0.53) TRPV1EPHX2
SCHEMBL25340961 0.79 TRPV1 (0.45) TRPV1
Ngd-8243 SCHEMBL2730820 0.77 TRPV1 (1.00) TRPV1
Ngd-8243 SCHEMBL29706343 0.77 TRPV1 (1.00) TRPV1
SCHEMBL25340324 0.77 TRPV1 (0.54) TRPV1
SCHEMBL25974211 0.77 TRPV1 (0.45) TRPV1CNR1EPHX2
SCHEMBL4970898 0.76 TRPV1 (0.79) TRPV1EGFREPHX2
SCHEMBL30482575 0.75 KCNQ3 (0.47) TRPV1EPHX2
SCHEMBL25378382 0.75 KCNQ3 (0.47) TRPV1EPHX2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023146511-A1 COMPOUNDS AND METHODS OF USE THEREOF VIVACE THERAPEUTICS, INC. (US) 2023-08-03 — — WO disclosed
WO-2023146511-A1 COMPOUNDS AND METHODS OF USE THEREOF VIVACE THERAPEUTICS, INC. (US) 2023-08-03 — — WO disclosed
Send feedback